Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3 - Image 1

£112.27

Springer Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3

Name: Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3
Brand: Springer
Price: 112.27 GBP
Availability: InStock

White

Physiology

This is the usual price. Wait for it to drop, or tell us your number.

£112 today · usual range £0–£0 · best ever £103

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 596 days • 596 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 596 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (212 days, 35.6%)

Price range: £103 - £113

Price levels: 7 different prices over 596 days

Description

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer. Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine etc. have been isolated and purified from these medicinal plants. Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk. “Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

Product Specifications

Brand: Springer
Colour: White
Format: hardcover
ASIN: 9811082154
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Animal Sciences > Physiology
Domain: Amazon UK
Release Date: 14 July 2018
Listed Since: 28 December 2017

Barcode

No barcode data available

Springer Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Antitumoral Properties of Natural Products

Anticancer Agents from Natural Products

Anticancer Agents from Natural Products

Handbook of Compounds with Cytotoxic Activity Isolated from Plants

Natural Products as Anticancer Agents

Antitumoral Properties of Natural Products: Volume 2

Nano-formulation of Dietary Phytochemicals for Cancer Management

Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients, and Pharmacological Outcomes

Springer Anticancer Plants: Mechanisms and Molecular Interactions

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

The Chemistry of Antitumour Agents

Evidence-based Anticancer Materia Medica (Evidence-based Anticancer Complementary and Alternative Medicine)

Evidence-based Anticancer Materia Medica: 0 (Evidence-based Anticancer Complementary and Alternative Medicine)

Oncological Functional Nutrition: Phytochemicals and Medicinal Plants

Phytopharmaceuticals in Cancer Chemoprevention: 2 (CRC Series in Modern Nutrition Science)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and their Chemoresistance: Part 3. Potential Pharmaceuticals to Overcome ... (Advances in Botanical Research, Volume 115)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)